ON THE QUESTION OF DIASTOLIC DYSFUNCTION OF THE LEFT VENTRICLE IN METABOLIC SYNDROME

dc.contributor.author	Tashtemirova Irodaxon Makamboyevna
dc.date.accessioned	2025-12-31T15:36:01Z
dc.date.issued	2022-03-31
dc.description.abstract	In this article, an epidemic of metabolic diseases is currently approaching - obesity, diabetes mellitus (DM), arterial hypertension (AH). Analyzes have been reported that the proportion of the population with metabolic syndrome (MS) leading to the development of type 2 diabetes and cardiovascular disease (CVD) is growing faster. Predicting the progression of Metabolic Syndrome is determined not only by blood pressure (BP), glycemic control level, and metabolic disorders, but also by heart remodeling
dc.format	application/pdf
dc.identifier.uri	https://scholarexpress.net/index.php/wbph/article/view/750
dc.identifier.uri	https://asianeducationindex.com/handle/123456789/48889
dc.language.iso	eng
dc.publisher	Scholar Express Journals
dc.relation	https://scholarexpress.net/index.php/wbph/article/view/750/675
dc.rights	https://creativecommons.org/licenses/by-nc-nd/4.0
dc.source	World Bulletin of Public Health; Vol. 8 (2022): WBPH; 183-185
dc.source	2749-3644
dc.subject	Metabolic Syndrome
dc.subject	direct correlation
dc.subject	systolic parameters
dc.subject	diastolic filling
dc.title	ON THE QUESTION OF DIASTOLIC DYSFUNCTION OF THE LEFT VENTRICLE IN METABOLIC SYNDROME
dc.type	info:eu-repo/semantics/article
dc.type	info:eu-repo/semantics/publishedVersion
dc.type	Peer-reviewed Article

item.page.files

pagination.showing.labelpagination.showing.detail

item.page.filesection.name: makamboyevna_2022_on_the_question_of_diastolic_dysfunction.pdf
item.page.filesection.size: 173.59 KB
item.page.filesection.format: Adobe Portable Document Format